VENORUTON 300
300MG CPS DUR 50
| SÚKL code | 0218100 |
|---|---|
| Name of the product | VENORUTON 300 |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | VENORUTON 300 |
| Supplement | 300MG CPS DUR 50 |
| Strenght | 300MG |
| Pharmaceutical form | Capsule, hard |
| Package | 50 |
| Route | Oral use |
| Wrap type | Blister |
| Legal status | OTC medicinal products |
| Active substance | OXERUTINS (OXERUTINA) |
| ATC group | C05CA54 |
| ATC group name | TROXERUTIN, KOMBINACE |
Marketing authorisation information
| Registration Number | 85/ 514/70-C |
|---|---|
| Type of MA | National |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 03. 2021 |
| MA Holder | GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o., Praha |
| MA Holder country | ČESKÁ REPUBLIKA |
| Actual MA holder | STADA Arzneimittel AG, Bad Vilbel |
| Actual MA holder country | NĚMECKO |
cz